• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ligand-restricted synNotch switches enable precision cell therapy.配体限制型合成Notch开关实现精准细胞治疗。
Trends Immunol. 2025 Feb;46(2):91-93. doi: 10.1016/j.it.2025.01.005. Epub 2025 Jan 28.
2
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma.SynNotch-CAR T 细胞在治疗脑胶质瘤中克服了特异性、异质性和持久性方面的挑战。
Sci Transl Med. 2021 Apr 28;13(591). doi: 10.1126/scitranslmed.abe7378.
3
Engineering a Programmed Death-Ligand 1-Targeting Monobody Via Directed Evolution for SynNotch-Gated Cell Therapy.通过定向进化工程化一种程序性死亡配体 1 靶向单域抗体用于 SynNotch 门控细胞治疗。
ACS Nano. 2024 Mar 19;18(11):8531-8545. doi: 10.1021/acsnano.4c01597. Epub 2024 Mar 8.
4
Synthetic cytokine circuits that drive T cells into immune-excluded tumors.合成细胞因子电路将 T 细胞驱入免疫排斥肿瘤中。
Science. 2022 Dec 16;378(6625):eaba1624. doi: 10.1126/science.aba1624.
5
SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models.SynNotch CAR 电路增强实体瘤识别并促进小鼠模型中的持续抗肿瘤活性。
Sci Transl Med. 2021 Apr 28;13(591). doi: 10.1126/scitranslmed.abd8836.
6
SynNotch CAR-T cell, when synthetic biology and immunology meet again.合成Notch嵌合抗原受体T细胞,当合成生物学与免疫学再度相遇时。
Front Immunol. 2025 Apr 16;16:1545270. doi: 10.3389/fimmu.2025.1545270. eCollection 2025.
7
Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells.通过合成Notch受体工程化的NK92细胞对白细胞介素12进行靶标依赖性表达可增强嵌合抗原受体T细胞(CAR-T细胞)的抗肿瘤活性。
Front Oncol. 2019 Dec 19;9:1448. doi: 10.3389/fonc.2019.01448. eCollection 2019.
8
Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma.用于胶质母细胞瘤过继性细胞治疗的抗表皮生长因子受体III型嵌合抗原受体修饰的T细胞
Curr Pharm Des. 2017;23(14):2113-2116. doi: 10.2174/1381612823666170316125402.
9
CXCL10 encoding synNotch T cells enhance anti-tumor immune responses without systemic side effect.CXCL10 编码的 synNotch T 细胞增强抗肿瘤免疫反应而无全身副作用。
Biochem Biophys Res Commun. 2021 Jan 1;534:765-772. doi: 10.1016/j.bbrc.2020.11.002. Epub 2020 Nov 17.
10
Chimeric Antigen Receptor T-Cell Therapy: Updates in Glioblastoma Treatment.嵌合抗原受体 T 细胞疗法:胶质母细胞瘤治疗的新进展。
Neurosurgery. 2021 May 13;88(6):1056-1064. doi: 10.1093/neuros/nyaa584.

引用本文的文献

1
In Situ synNotch-Programmed Astrocytes Sense and Attenuate Neuronal Apoptosis.原位合成Notch编程的星形胶质细胞感知并减轻神经元凋亡。
Int J Mol Sci. 2025 May 2;26(9):4343. doi: 10.3390/ijms26094343.

本文引用的文献

1
Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs.工程化合成抑制性T细胞,执行局部靶向免疫保护程序。
Science. 2024 Dec 6;386(6726):eadl4793. doi: 10.1126/science.adl4793.
2
Programming tissue-sensing T cells that deliver therapies to the brain.对可向大脑输送治疗的组织感知T细胞进行编程。
Science. 2024 Dec 6;386(6726):eadl4237. doi: 10.1126/science.adl4237.
3
CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review.嵌合抗原受体T细胞及癌症T细胞疗法:转化科学综述
JAMA. 2024 Dec 10;332(22):1924-1935. doi: 10.1001/jama.2024.19462.
4
Programmable synthetic receptors: the next-generation of cell and gene therapies.可编程合成受体:下一代细胞和基因治疗。
Signal Transduct Target Ther. 2024 Jan 3;9(1):7. doi: 10.1038/s41392-023-01680-5.
5
Modular design of synthetic receptors for programmed gene regulation in cell therapies.用于细胞治疗中基因程序化调控的合成受体的模块化设计。
Cell. 2022 Apr 14;185(8):1431-1443.e16. doi: 10.1016/j.cell.2022.03.023.
6
CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications.嵌合抗原受体T调节(CAR-Treg)细胞:工程与应用
Biomedicines. 2022 Jan 26;10(2):287. doi: 10.3390/biomedicines10020287.
7
T cell circuits that sense antigen density with an ultrasensitive threshold.T 细胞具有超敏阈感知抗原密度的回路。
Science. 2021 Mar 12;371(6534):1166-1171. doi: 10.1126/science.abc1855. Epub 2021 Feb 25.
8
Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors.利用合成Notch受体构建具有定制治疗反应程序的工程化T细胞。
Cell. 2016 Oct 6;167(2):419-432.e16. doi: 10.1016/j.cell.2016.09.011. Epub 2016 Sep 29.
9
Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors.利用合成Notch受体设计定制化细胞传感与反应行为
Cell. 2016 Feb 11;164(4):780-91. doi: 10.1016/j.cell.2016.01.012. Epub 2016 Jan 28.
10
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.白细胞介素-10悖论:一种强大的免疫调节细胞因子,一直难以用于免疫治疗。
Cytokine. 2015 Jul;74(1):27-34. doi: 10.1016/j.cyto.2014.10.031. Epub 2014 Dec 4.

配体限制型合成Notch开关实现精准细胞治疗。

Ligand-restricted synNotch switches enable precision cell therapy.

作者信息

Li Xuyang, Hu Dan

机构信息

Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21205, USA; Ludwig Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; Lustgarten Dedicated Laboratory for Pancreatic Cancer Research and the Bloomberg~Kimmel Institute Cancer Genetics and Genomics Research Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Ann Romney Center for Neurologic Diseases, Harvard Medical School and Mass General Brigham, Boston, MA 02115, USA.

出版信息

Trends Immunol. 2025 Feb;46(2):91-93. doi: 10.1016/j.it.2025.01.005. Epub 2025 Jan 28.

DOI:10.1016/j.it.2025.01.005
PMID:39875238
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11835521/
Abstract

Lim and colleagues demonstrate that synNotch transcriptional circuits engineered into T cells can be used to precisely control location-specific expression of payloads responding to antigen triggers, thus locally inhibiting unwanted immunity or neuroinflammation. With no off-tumor toxicity or systemic immunosuppression upon elimination of mouse brain tumors, this approach can achieve better efficacy than anticipated.

摘要

林和同事们证明,工程改造到T细胞中的合成Notch转录回路可用于精确控制对抗原触发作出反应的有效载荷的位置特异性表达,从而局部抑制不必要的免疫或神经炎症。在消除小鼠脑肿瘤时没有肿瘤外毒性或全身免疫抑制,这种方法可以实现比预期更好的疗效。